Wird geladen...
The Efficacy and Safety of Initial Use of Irbesartan/Hydrochlorothiazide Fixed‐Dose Combination in Hypertensive Patients With and Without High Cardiovascular Risk
A post hoc pooled analysis of 2 multicenter, randomized, double‐blind, active‐controlled force‐titration studies assessed the antihypertensive efficacy and tolerability of 7 to 8 weeks' once‐daily fixed‐dose irbesartan/hydrochlorothiazide (HCTZ) 300/25 mg in 796 stage 1 or 2 hypertensive patien...
Gespeichert in:
| Veröffentlicht in: | J Clin Hypertens (Greenwich) |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Blackwell Publishing Inc
2007
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8110100/ https://ncbi.nlm.nih.gov/pubmed/18046109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2007.07805.x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|